DAVID PLATT - 24 Oct 2024 Form 4/A - Amendment Insider Report for BIOXYTRAN, INC (BIXT)

Role
CEO, Director, 10%+ Owner
Signature
David Platt
Issuer symbol
BIXT
Transactions as of
24 Oct 2024
Transactions value $
$2,216,887
Form type
4/A - Amendment
Filing time
18 Nov 2025, 15:54:45 UTC
Date Of Original Report
24 Oct 2024
Previous filing
20 Aug 2024
Next filing
28 Oct 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PLATT DAVID CEO, Director, 10%+ Owner 12 APPLETON CIRCLE, NEWTON David Platt 18 Nov 2025 0001166440

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIXT preferred Other -$4.01M -14.1M -100% $0.29 0 24 Oct 2024 through NDPD Pharma F1, F2
transaction BIXT preferred Other $6.23M +11.4M +132.86% $0.55 20M 24 Oct 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were returned to treasury and cancelled
F2 The total holdings of BIXT by NDPA Pharma, an affiliate whose beneficial ownership includes David Platt, Ola Soderquist and Mike Sheikh were consolidated under indirect ownership in David Platt's filing
F3 The shares were issued as payment for the sale of NDPD to Bioxytran